Working… Menu

Symptom Management in African-American Men With Localized Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00767845
Recruitment Status : Withdrawn (No subjects were enrolled here or at UCSF.)
First Posted : October 7, 2008
Last Update Posted : November 9, 2016
Information provided by (Responsible Party):
David Latini, Baylor College of Medicine

Brief Summary:

RATIONALE: Gathering information about symptom management from patients with localized prostate cancer may help doctors improve patients' quality of life.

PURPOSE: This clinical trial is studying symptom management in African-American men with localized prostate cancer.

Condition or disease Intervention/treatment
Prostate Cancer Psychosocial Effects of Cancer and Its Treatment Other: questionnaire/survey administration

Detailed Description:


  • Develop a symptom management intervention for African-American men treated for localized prostate cancer, with a particular emphasis on low health literacy men.

OUTLINE: Participants are interviewed by the principal investigator over the phone or meet the principal investigator at the Veterans Administration prostate cancer clinic. If the interview is conducted in the clinic, it is held in a private room in the clinic.

Layout table for study information
Study Type : Observational
Actual Enrollment : 0 participants
Study Start Date : June 2006
Actual Primary Completion Date : May 2008
Actual Study Completion Date : May 2008

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Symptom management taxonomy

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 120 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No


  • Biopsy-proven localized prostate cancer

    • Has received treatment for prostate cancer
  • Patient self-identifies as being of African-American descent


  • Able to speak and read in English
  • Has an address in order to receive study materials by mail (a street address or post office box)
  • Has either a telephone in order to be interviewed OR is able to meet the principal investigator at the Veterans Administration prostate clinic and be interviewed there


  • See Disease Characteristics

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00767845

Layout table for location information
United States, Texas
Dan L. Duncan Cancer Center at Baylor College of Medicine
Houston, Texas, United States, 77030
Sponsors and Collaborators
Baylor College of Medicine
Layout table for investigator information
Principal Investigator: David M. Latini, PhD Baylor College of Medicine

Layout table for additonal information
Responsible Party: David Latini, Assistant Professor, Baylor College of Medicine Identifier: NCT00767845     History of Changes
Other Study ID Numbers: CDR0000600455
First Posted: October 7, 2008    Key Record Dates
Last Update Posted: November 9, 2016
Last Verified: November 2016
Keywords provided by David Latini, Baylor College of Medicine:
psychosocial effects of cancer and its treatment
stage I prostate cancer
stage II prostate cancer
stage III prostate cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Genital Diseases, Male
Prostatic Diseases